Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;75(4):1056-1057.
doi: 10.1002/hep.32291. Epub 2022 Jan 6.

Letter to the editor: Serum thrombospondin-2 as biomarker in liver diseases, a look beyond NASH

Tania Colasanti  1 , Alessandra Di Giamberardino  2 , Alessio Grimaldi  2 , Vincenzo Cardinale  3 , Guido Carpino  4 , Carmine Mancone  2
Affiliations
Comment

Letter to the editor: Serum thrombospondin-2 as biomarker in liver diseases, a look beyond NASH

Tania Colasanti et al. Hepatology. 2022 Apr.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Kodama T, Takehara T. Kodama T, et al. Hepatology. 2022 Apr;75(4):1058. doi: 10.1002/hep.32292. Epub 2022 Jan 5. Hepatology. 2022. PMID: 34927750 No abstract available.

Comment on

References

    1. Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, et al. Transcriptomics identify thrombospondin‐2 as a biomarker for NASH and advanced liver fibrosis. Hepatology. 2021;74:2452–66.
    1. Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, et al. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1377–86.
    1. Le Large TYS, Meijer LL, Paleckyte R, Boyd LNC, Kok B, Wurdinger T, et al. Combined expression of plasma thrombospondin‐2 and CA19‐9 for diagnosis of pancreatic cancer and distal cholangiocarcinoma: a proteome approach. Oncologist. 2020;25:e634–43.